Skip to main content

Advertisement

Log in

Safflower yellow ameliorates cognition deficits and reduces tau phosphorylation in APP/PS1 transgenic mice

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Alzheimer’s disease (AD), the most common cause of dementia worldwide, is mainly characterized by the aggregated β-amyloid (Aβ) and hyperphosphorylated tau. Safflower yellow (SY) is a novel water extract of natural safflower and has been suggested to ameliorate memory deficits in several animal models of dementia. In this study, we aimed to investigate the effect and mechanism of SY on deficits of learning and memory and hyperphosphorylation of tau in APP/PS1 double transgenic mice. APP/PS1 mice were administered with SY (10, 30, 100 mg/kg) by oral gavage for three months at the age of six months. The ability of learning and memory was investigated using the step-down test and Morris water maze test, and protein level in the brain was evaluated using western blot. Here, we found that SY treatment can improve spatial learning and memory ability, and reduce tau hyperphosphorylation at Ser199, Thr205, Ser396, Ser404 sites in APP/PS1 mice. In addition, the activity the of cyclin-dependent kinase 5 (CDK-5) and glycogen synthase kinase 3β (GSK-3β), major kinases involved in tau phosphorylation, was siginificantly decreased in APP/PS1 mice by SY treatment. These results support SY can serve as a promising multitarget neuronal therapeutic agent for the treatment of AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosci 8:663–672

    Article  CAS  PubMed  Google Scholar 

  • Chen L, Ding L, Zhang H, Li J, Wang Y, Wang X, Qu C, Zhang H (2006) Dynamic microwave-assisted extraction coupled with on-line spectrophotometric determination of safflower yellow in Flos Carthami. Anal Chim Acta 580:75–82

    Article  CAS  PubMed  Google Scholar 

  • Chin PC, Majdzadeh N, D’Mello SR (2005) Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Res Mol Brain Res 137:193–201

    Article  CAS  PubMed  Google Scholar 

  • Cohen P, Frame S (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769–776

    Article  CAS  PubMed  Google Scholar 

  • Dhariwala FA, Rajadhyaksha MS (2008) An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol 28:351–369

    Article  CAS  PubMed  Google Scholar 

  • Dolan PJ, Johnson GV (2010) The role of tau kinases in Alzheimer’s disease. Curr Opin Drug Discov Devel 13:595–603

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2 A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem 275:5535–5544

    Article  CAS  PubMed  Google Scholar 

  • Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, Seereeram A, Reynolds CH, Ward MA, Anderton BH (2007) Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem 282:23645–23654

    Article  CAS  PubMed  Google Scholar 

  • Hanger DP, Anderton BH, Noble W (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15:112–119

    Article  CAS  PubMed  Google Scholar 

  • Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B (2000) Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2:461–462

    Article  CAS  PubMed  Google Scholar 

  • Hu YL, Wang PL, Zhang Y, Liu M (2012) Effects of safflower yellow on learning and memory impairments on scopolamine-induced dementia in mice. Chin J Gerontol 19:4197–4198

    Google Scholar 

  • Huang HC, Jiang ZF (2009) Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer’s disease. J Alzheimers Dis 16:15–27

    CAS  PubMed  Google Scholar 

  • Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739:198–210

    Article  CAS  PubMed  Google Scholar 

  • Iqbal K, Liu F, Gong CX, Grundke-Iqbal I (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7:656–664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jayapalan S, Natarajan J (2013) The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer’s disease. Bioinformation 9:1023–1030

    Article  PubMed  PubMed Central  Google Scholar 

  • Jessberger S, Aigner S, Clemenson GJ, Toni N, Lie DC, Karalay O, Overall R, Kempermann G, Gage FH (2008) Cdk5 regulates accurate maturation of newborn granule cells in the adult hippocampus. PLoS Biol 6:e272

    Article  PubMed  PubMed Central  Google Scholar 

  • Kurt MA, Davies DC, Kidd M, Duff K, Howlett DR (2003) Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Neurobiol Dis 14:89–97

    Article  CAS  PubMed  Google Scholar 

  • Li HX, Han SY, Wang XW, Ma X, Zhang K, Wang L, Ma ZZ, Tu PF (2009) Effect of the carthamins yellow from Carthamus tinctorius L. On hemorheological disorders of blood stasis in rats. Food Chem Toxicol 47(8):1797–1802

    Article  CAS  PubMed  Google Scholar 

  • Li CC, Yang CZ, Li XM, Zhao XM, Zou Y, Fan L, Zhou L, Liu JC, Niu YC (2012) Hydroxysafflor yellow a induces apoptosis in activated hepaticstellate cells through ERK1/2 pathway in vitro. Eur J Pharm Sci 46(5):397–404

    Article  CAS  PubMed  Google Scholar 

  • Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22:1942–1950

    Article  PubMed  Google Scholar 

  • Liu Y, Lian Z, Zhu H, Wang Y, Yu S, Chen T, Qu J, Li J, Ma S, Chen X (2013) A systematic, integrated study on the neuroprotective effects of hydroxysafflor yellow a revealed by (1)H NMR-based Metabonomics and the NF-kappaB pathway. Evid Based Complement Alternat Med 2013:147362

    PubMed  PubMed Central  Google Scholar 

  • Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20:27–39

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ma Q, Ruan YY, Xu H, Shi XM, Wang ZX, Hu YL (2015) Safflower yellow reduces lipid peroxidation, neuropathology, tau phosphorylation and ameliorates amyloid β-induced impairment of learning and memory in rats. Biomed Pharmacother 76:153–164

  • Maas T, Eidenmuller J, Brandt R (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem 275:15733–15740

    Article  CAS  PubMed  Google Scholar 

  • Meselhy MR, Kadota S, Momose Y, Hatakeyama N, Kusai A, Hattori M, et al. (1993) Two new quinochalcone yellow pigments from Carthamus tinctorius and Ca2 þantagonistic activity of tinctormine. Chem Pharm Bull 41(10):1796–1802

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez-Martin T, Cuchillo-Ibanez I, Noble W, Nyenya F, Anderton BH, Hanger DP (2013) Tau phosphorylation affects its axonal transport and degradation. Neurobiol Aging 34:2146–2157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M, Buee L (2006) Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169:599–616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Selkoe DJ (2001) Alzheimer’s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3:75–80

    CAS  PubMed  Google Scholar 

  • Sengupta A, Novak M, Grundke-Iqbal I, Iqbal K (2006) Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level. FEBS Lett 580:5925–5933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shelton SB, Johnson GV (2004) Cyclin-dependent kinase-5 in neurodegeneration. J Neurochem 88:1313–1326

    Article  CAS  PubMed  Google Scholar 

  • Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CR (2004) Altered expression levels of the protein phosphatase 2 A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63:287–301

    Article  CAS  PubMed  Google Scholar 

  • Takahashi Y, Miyasaka N, Tasaka S, Miura I, Urano S, Ikura M, et al. (1982) Constitution of two coloring matters in the flower petals of Carthamus tinctorius L. Tetrahedron Lett 23:51–63

    Article  Google Scholar 

  • Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K (1998) Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett 436:28–34

    Article  CAS  PubMed  Google Scholar 

  • Wang CC, Choy CS, Liu YH, Cheah KP, Li JS, Wang JT, Yu WY, Lin CW, Cheng HW, Hu CM (2011) Protective effect of dried safflower petal aqueous extract and its main constituent, carthamus yellow, againstlipopolysaccharide-induced inflammation in RAW264.7 macrophages. J Sci Food Agric 91(2):218–225

    Article  CAS  PubMed  Google Scholar 

  • Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE (2008) Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci 28:2624–2632

    Article  CAS  PubMed  Google Scholar 

  • Xu H, Ma Q, Wang ZX, Hu YL (2013) Effects of safflower yellow on D-galactose/sodium nitrite induced learning and memory disorders in mice. Chin J Gerontol 29:59–61

    CAS  Google Scholar 

  • Yang Z, Yang J, Jia Y, Tian Y, Wen A (2009) Pharmacokinetic properties of hydroxysafflor yellow a in healthy Chinese female volunteers. J Ethnopharmacol 124:635–638

    Article  CAS  PubMed  Google Scholar 

  • Zhang Z, Nadeau P, Song W, Donoviel D, Yuan M, Bernstein A, Yankner BA (2000) Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of notch-1. Nat Cell Biol 2:463–465

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Natural Science Foundation of China (No.81360495).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yan-li Hu.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruan, Yy., Zhai, W., Shi, Xm. et al. Safflower yellow ameliorates cognition deficits and reduces tau phosphorylation in APP/PS1 transgenic mice. Metab Brain Dis 31, 1133–1142 (2016). https://doi.org/10.1007/s11011-016-9857-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-016-9857-3

Keywords

Navigation